查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604729

心房中膈缺損症市場：依症狀、依應用分類 - 2025-2030 年全球預測

Atrial Septal Defect Market by Symptoms (Dyspnea, Fatigue, Frequent Respiratory Infections), Application (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心房中膈缺損症市場價值為57億美元，預計到2024年將達到60.5億美元，複合年成長率為6.29%，到2030年將達到87.3億美元。

心房中膈缺損症（ASD）是一種先天性心臟結構異常，其特徵是房間隔上有一個洞，導致血液在左右心房之間流動。自閉症譜系障礙 (ASD) 治療的需要源於疲勞、呼吸短促等症狀，以及如果不治療則有中風和心臟衰竭等併發症的風險。最終用途包括微創手術、基於導管的干涉措施和設備植入，包括醫院、門診外科中心和心臟診所。市場成長的推動因素包括意識和診斷率的提高、外科手術技術的進步以及易患心臟病的老年人口的增加。主要商機在醫療基礎設施不斷改善、醫療保健支出不斷增加的新興市場。此外，生物分解性植入和機器人輔助手術系統的進步是一個有前景的投資和創新領域。然而，市場面臨著手術成本上升、低收入地區的准入有限、後勤複雜性以及術後併發症的可能性等挑戰，導致需要具有成本效益的干涉措施和醫療保健提供者，這表明需要改進培訓。此外，監管挑戰和對植入技術進行嚴格臨床檢驗的需求可能會阻礙新產品快速進入市場。非侵入性診斷技術的創新、使用人工智慧的個人化治療計劃以及開發具有成本效益的治療方法為研究和業務成長提供了重要途徑。總體而言，自閉症譜系障礙治療市場是一個競爭激烈但前景廣闊的市場，越來越重視早期診斷和早期療育，並且在改善患者治療效果、可負擔性和可及性方面具有巨大的創新空間，您可以說這是一個市場。公司可以透過重視與醫療保健提供者的策略夥伴關係關係並投資於突破性技術的研發來維持並最大限度地發揮其成長潛力。

主要市場統計
基準年[2023] 57億美元
預計年份 [2024] 60.5億美元
預測年份 [2030] 87.3億美元
複合年成長率（%） 6.29%

市場動態：快速發展的心房中膈缺損症市場的關鍵市場洞察

心房中膈缺損症市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 遺傳性心臟疾病盛行率上升
    • 政府和公共機構加強對心房中膈缺損症的認知宣傳活動
    • 採用心臟 MRI
  • 市場限制因素
    • 經皮缺損封堵術的解剖學局限性
  • 市場機會
    • 先天性心臟疾病治療技術進展
    • 政府對 ASD 治療給予優惠報銷
  • 市場挑戰
    • ASD 手術期間的併發症和副作用

波特五力：駕馭心房中膈缺損症市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心房中膈缺損症市場的外部影響

外部宏觀環境因素在塑造心房中膈缺損症市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心房中膈缺損症市場的競爭格局

心房中膈缺損症市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心房中膈缺損症市場供應商的績效評估

FPNV 定位矩陣是評估心房中膈缺損症市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心房中膈缺損症市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對心房中膈缺損症市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遺傳性心臟病的發生率增加
      • 政府和公共機構擴大對心房中膈缺損症的認知宣傳活動
      • 心臟MRI檢查簡介
    • 抑制因素
      • 經皮缺損封堵術的解剖學局限性
    • 機會
      • 先天性心臟疾病治療技術進展
      • 政府對 ASD 治療給予優惠報銷
    • 任務
      • ASD 手術期間的併發症和副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心房中膈缺損症市場（依症狀）

  • 呼吸困難
  • 疲勞
  • 頻繁呼吸道感染疾病
  • 心悸
  • 腿和腳腫脹

第7章心房中膈缺損症市場：依應用分類

  • 門診手術中心
  • 醫院
  • 專科診所

第8章 北美和南美心房中膈缺損症市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太房心房中膈缺損症市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲心房中膈缺損症市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Asklepion Pharmaceuticals, LLC
  • AtriCure, Inc
  • Carag AG
  • GE HealthCare Technologies, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd
  • Lifetech Scientific
  • Medtronic PLC
  • Occlutech GmbH
  • Siemens AG
  • WL Gore & Associates, Inc.
Product Code: MRR-CA17E905E9C1

The Atrial Septal Defect Market was valued at USD 5.70 billion in 2023, expected to reach USD 6.05 billion in 2024, and is projected to grow at a CAGR of 6.29%, to USD 8.73 billion by 2030.

Atrial Septal Defect (ASD) is a congenital structural heart defect characterized by a hole in the atrial septum, allowing blood to flow between the left and right atria. The necessity for ASD treatments stems from symptoms like fatigue, shortness of breath, and risk of complications such as stroke or heart failure in untreated cases. Applications include minimally invasive surgical procedures, catheter-based interventions, and device implants, with end-use sectors such as hospitals, outpatient surgical centers, and specialty cardiac clinics. Market growth is fueled by increasing awareness and diagnosis rates, technological advancements in surgical techniques, and a growing geriatric population susceptible to heart defects. Key opportunities lie in emerging markets with improving healthcare infrastructure and increasing healthcare expenditure. Additionally, advancements in biodegradable implants and robotic-assisted surgery systems represent promising areas for investment and innovation. However, the market faces challenges including high costs of procedures, limited accessibility in low-income regions, logistical complexities, and potential post-operative complications, suggesting the need for cost-effective interventions and improved training for healthcare professionals. Moreover, regulatory challenges and the need for rigorous clinical validation in implant technologies can impede rapid market entry of new products. Innovations in non-invasive diagnostic techniques, personalized treatment plans using artificial intelligence, and the development of cost-efficient therapeutic treatments offer significant avenues for research and business growth. Overall, the ASD treatment market demonstrates a competitive yet promising landscape, driven by an increasing emphasis on early diagnosis and intervention, with substantial room for technological innovation to enhance patient outcomes, affordability, and accessibility. Businesses should focus on strategic partnerships with healthcare providers and invest in R&D for breakthrough technologies to sustain and maximize growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 5.70 billion
Estimated Year [2024] USD 6.05 billion
Forecast Year [2030] USD 8.73 billion
CAGR (%) 6.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Septal Defect Market

The Atrial Septal Defect Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalences of genetic heart disorders
    • Growing awareness campaigns regarding atrial septal defects by government and public organizations
    • Adoption of cardiac MRI procedures
  • Market Restraints
    • Anatomical limitations to percutaneous ASD closure
  • Market Opportunities
    • Technological advancement in the treatment of congenital heart diseases
    • Favorable government reimbursements for ASD treatment
  • Market Challenges
    • Complication and side effects during ASD surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Septal Defect Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Septal Defect Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Septal Defect Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Septal Defect Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Septal Defect Market

A detailed market share analysis in the Atrial Septal Defect Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Septal Defect Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Septal Defect Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Septal Defect Market

A strategic analysis of the Atrial Septal Defect Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Septal Defect Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asklepion Pharmaceuticals, LLC, AtriCure, Inc, Carag AG, GE HealthCare Technologies, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Lifetech Scientific, Medtronic PLC, Occlutech GmbH, Siemens AG, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Atrial Septal Defect Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Symptoms, market is studied across Dyspnea, Fatigue, Frequent Respiratory Infections, Heart Palpitations, and Swelling of Legs & Feet.
  • Based on Application, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of genetic heart disorders
      • 5.1.1.2. Growing awareness campaigns regarding atrial septal defects by government and public organizations
      • 5.1.1.3. Adoption of cardiac MRI procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Anatomical limitations to percutaneous ASD closure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the treatment of congenital heart diseases
      • 5.1.3.2. Favorable government reimbursements for ASD treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Complication and side effects during ASD surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Atrial Septal Defect Market, by Symptoms

  • 6.1. Introduction
  • 6.2. Dyspnea
  • 6.3. Fatigue
  • 6.4. Frequent Respiratory Infections
  • 6.5. Heart Palpitations
  • 6.6. Swelling of Legs & Feet

7. Atrial Septal Defect Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Atrial Septal Defect Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Atrial Septal Defect Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Atrial Septal Defect Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asklepion Pharmaceuticals, LLC
  • 3. AtriCure, Inc
  • 4. Carag AG
  • 5. GE HealthCare Technologies, Inc.
  • 6. Johnson & Johnson Services, Inc.
  • 7. Lepu Medical Technology (Beijing) Co., Ltd
  • 8. Lifetech Scientific
  • 9. Medtronic PLC
  • 10. Occlutech GmbH
  • 11. Siemens AG
  • 12. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. ATRIAL SEPTAL DEFECT MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL SEPTAL DEFECT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL SEPTAL DEFECT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL SEPTAL DEFECT MARKET DYNAMICS
  • TABLE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS & FEET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023